查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604755

自體免疫疾病診斷市場：按類型、適應症、測試、產品和最終用戶分類 - 全球預測 2025-2030

Autoimmune Disease Diagnostics Market by Type (Localized Autoimmune Disease Diagnostics, Systemic Autoimmune Disease Diagnostics), Indication (Addison Disease, Celiac Disease, Dermatomyositis), Test, Product, End User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，自體免疫疾病診斷市值為50.8億美元，預計2024年將達到55.3億美元，複合年成長率為9.06%，到2030年將達到93.3億美元。

自體免疫疾病診斷市場包括一系列旨在檢測自體免疫疾病的測試和程序，其中人體的免疫系統錯誤地攻擊健康細胞。這個市場至關重要，因為類風濕性關節炎、紅斑性狼瘡和多發性硬化症等自體免疫疾病越來越普遍，通常需要及時、準確的診斷才能進行有效的治療。診斷應用於許多平台，包括基於實驗室的測定和就地檢驗，最終用途為醫院、診斷中心和研究機構。關鍵的成長要素包括自體免疫疾病的擴散、診斷技術的進步以及醫療保健專業人員和患者意識的提高。利用人工智慧和機器學習來提高診斷測試的預測準確性和效率並開發更個性化的診斷工具存在潛在的機會。公司可以透過投資研發來利用這些趨勢，旨在開發強大、易於使用的診斷解決方案，以快速提供準確的結果。

主要市場統計
基準年[2023] 50.8億美元
預測年份 [2024] 55.3億美元
預測年份 [2030] 93.3億美元
複合年成長率（%） 9.06%

該市場面臨診斷成本高、缺乏標準化以及缺乏熟練專業人員等挑戰，阻礙了更廣泛的採用。此外，由於不同自體免疫疾病的症狀重疊而導致的誤診也是一個主要問題。為了克服這些問題，可以採取經濟高效的診斷解決方案、標準化程序和培訓計劃等創新來提高醫護人員的能力。我們也應專注於尋找新的生物標記物，研發非侵入性、快速的檢測方法。為了推動業務成長，公司應強調臨床試驗和市場滲透的合作和夥伴關係。此外，還需要解決與基於人工智慧的診斷相關的區域監管要求和潛在的道德問題。市場競爭激烈，各公司努力透過策略性合併、收購和突破性產品開拓來加強其診斷產品組合。總之，自體免疫疾病診斷市場透過創新和策略合作具有巨大的成長潛力，但需要解決現有的局限性，並需要有效利用新技術進步。

市場動態：快速發展的自體免疫疾病診斷市場的關鍵市場洞察

供需的動態交互作用正在改變自體免疫疾病診斷市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，並了解消費行為及其對製造成本的影響，並更清楚地了解對採購趨勢的影響。

  • 市場促進因素
    • 類風濕性關節炎、格雷夫茲病和橋本甲狀腺炎等自體免疫疾病的發生率增加
    • 關於自體免疫疾病的公眾意識和有利的政府舉措
    • 檢驗技術的改進和自動化
  • 市場限制因素
    • 誤報率高
    • 診斷測試的周轉時間緩慢
  • 市場機會
    • 採用生物感測器診斷自體免疫疾病
    • 醫生和臨床實驗室之間的策略夥伴關係
    • 試劑租賃協議和合作研究的潛在成長
  • 市場挑戰
    • 與診斷過程相關的費用

波特五力：駕馭自體免疫疾病診斷市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解自體免疫疾病診斷市場的外部影響

外部宏觀環境因素在塑造自體免疫疾病診斷市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解自體免疫疾病診斷市場的競爭狀況

對自體免疫疾病診斷市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV定位矩陣自體免疫疾病診斷市場供應商績效評估

FPNV定位矩陣是評估自體免疫疾病診斷市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議描繪了自體免疫疾病診斷市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，自體免疫疾病診斷市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告提供了涵蓋關鍵重點領域的市場全面分析：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 類風濕性關節炎、格雷夫茲病和橋本氏症等自體免疫疾病的發生率增加
      • 關於自體免疫疾病的公眾意識和首選政府舉措
      • 提高實驗室技術和自動化
    • 抑制因素
      • 假陽性結果發生率高
      • 診斷測試週轉時間很慢
    • 機會
      • 採用生物感測器診斷自體免疫疾病
      • 醫生和臨床實驗室之間的策略夥伴關係
      • 試劑租賃協議和聯合活動的潛在成長
    • 任務
      • 與診斷過程相關的費用
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章自體免疫疾病診斷市場：按類型

  • 局部自體免疫疾病診斷
  • 系統性自體免疫疾病診斷

第7章依適應症分類的自體免疫疾病診斷市場

  • 愛迪生氏症
  • 乳糜瀉
  • 皮肌炎
  • 格雷夫茲病
  • 橋本氏甲狀腺炎
  • 多發性硬化症
  • 重症肌無力
  • 惡性貧血
  • 反應性關節炎
  • 類風濕性關節炎
  • 修格蘭氏症候群
  • 全身性紅斑性狼瘡
  • 1型糖尿病

第8章自體免疫疾病診斷市場測試

  • 自體抗體和免疫學測試
    • 抗環瓜氨酸肽
    • 抗核抗體
    • C反應蛋白
    • 紅血球沉積速率
    • 類風濕因子
    • 甲狀腺抗體測試
      • T3
      • T3RU
      • T4
      • TSH
  • 發炎標記物
  • 定期臨床檢查

第9章自體免疫疾病診斷市場：依產品

  • 耗材和檢測試劑套件
  • 診斷設備

第10章自體免疫疾病診斷市場：依最終用戶分類

  • 臨床實驗室
  • 醫院

第11章 北美和南美自體免疫疾病診斷藥物市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第12章亞太地區自體免疫疾病診斷市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第13章歐洲、中東和非洲自體免疫疾病診斷市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第14章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Abbott Laboratories
  • AESKU.GROUP GmbH & Co. KG
  • AstraZeneca PLC
  • Beckman Coulter, Inc.
  • Bio-Rad Laboratories, Inc.
  • BioAgilytix Labs
  • Biogenuix Medsystems Private Limited
  • bioMerieux SA
  • EUROIMMUN Medical Laboratory Diagnostics AG
  • Exagen Inc.
  • F. Hoffmann-La Roche AG
  • Hemagen Diagnostics, Inc.
  • Novartis AG
  • Pfizer Inc.
  • Quest Diagnostics
  • Sanofi SA
  • SD BioSensor Inc.
  • Siemens Healthineers AG
  • SQI Diagnostics
  • Thermo Fisher Scientific Inc.
  • Trinity Biotech PLC
  • Werfen Group
Product Code: MRR-436901065F36

The Autoimmune Disease Diagnostics Market was valued at USD 5.08 billion in 2023, expected to reach USD 5.53 billion in 2024, and is projected to grow at a CAGR of 9.06%, to USD 9.33 billion by 2030.

The autoimmune disease diagnostics market encompasses a wide range of tests and procedures designed to detect autoimmune disorders, where the body's immune system mistakenly attacks its own healthy cells. This market is essential as autoimmune diseases, such as rheumatoid arthritis, lupus, and multiple sclerosis, are increasingly prevalent and often require timely and accurate diagnosis for effective management. The diagnostics are applied across many platforms, including laboratory-based assays and point-of-care tests, which cater to hospitals, diagnostic centers, and research institutions as end-use segments. Key growth factors include the surge in autoimmune disease incidences, advances in diagnostic technology, and heightened awareness among healthcare professionals and patients. Potential opportunities exist in the development of more personalized diagnostic tools, leveraging AI and machine learning to improve the predictive accuracy and efficiency of diagnostic tests. Companies can capitalize on these trends by investing in R&D aimed at creating robust, easy-to-use diagnostic solutions that deliver precise results swiftly.

KEY MARKET STATISTICS
Base Year [2023] USD 5.08 billion
Estimated Year [2024] USD 5.53 billion
Forecast Year [2030] USD 9.33 billion
CAGR (%) 9.06%

The market faces challenges such as high diagnostic costs, lack of standardization, and a shortage of skilled professionals, hindering broader adoption. Additionally, misdiagnosis due to overlapping symptoms of different autoimmune diseases poses significant challenges. To overcome these, innovations in cost-effective diagnostic solutions, standardized procedures, and training programs to enhance the competence of healthcare providers can be pursued. Research should also focus on identification of novel biomarkers and development of non-invasive, rapid testing methods. To foster business growth, firms should emphasize collaborations and partnerships for clinical trials and market penetration. Furthermore, adapting to regulatory requirements across regions and addressing potential ethical concerns associated with AI-driven diagnostics will be necessary. The nature of the market is competitive with companies striving to enhance their diagnostic portfolios through strategic mergers, acquisitions, and breakthrough product development. In summary, the autoimmune disease diagnostics market offers substantial growth potential through innovation and strategic alignment but requires addressing existing limitations and leveraging new technological advancements efficiently.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Autoimmune Disease Diagnostics Market

The Autoimmune Disease Diagnostics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
    • Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
    • Improved Laboratory Techniques and Automation
  • Market Restraints
    • High Frequency of False Positive Results
    • Slow Turnaround Time for Diagnostic Test
  • Market Opportunities
    • Adoption of Biosensors for Autoimmune Disease Diagnosis
    • Strategic Partnerships Between Physicians and Clinical Laboratories
    • Potential Growth in Reagent Rental Agreements and Collaboration Activities
  • Market Challenges
    • Cost associated with the diagnosis process

Porter's Five Forces: A Strategic Tool for Navigating the Autoimmune Disease Diagnostics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Autoimmune Disease Diagnostics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Autoimmune Disease Diagnostics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Autoimmune Disease Diagnostics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Autoimmune Disease Diagnostics Market

A detailed market share analysis in the Autoimmune Disease Diagnostics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Autoimmune Disease Diagnostics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Autoimmune Disease Diagnostics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Autoimmune Disease Diagnostics Market

A strategic analysis of the Autoimmune Disease Diagnostics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Autoimmune Disease Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AESKU.GROUP GmbH & Co. KG, AstraZeneca PLC, Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., BioAgilytix Labs, Biogenuix Medsystems Private Limited, bioMerieux SA, EUROIMMUN Medical Laboratory Diagnostics AG, Exagen Inc., F. Hoffmann-La Roche AG, Hemagen Diagnostics, Inc., Novartis AG, Pfizer Inc., Quest Diagnostics, Sanofi S.A., SD BioSensor Inc., Siemens Healthineers AG, SQI Diagnostics, Thermo Fisher Scientific Inc., Trinity Biotech PLC, and Werfen Group.

Market Segmentation & Coverage

This research report categorizes the Autoimmune Disease Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Localized Autoimmune Disease Diagnostics and Systemic Autoimmune Disease Diagnostics.
  • Based on Indication, market is studied across Addison Disease, Celiac Disease, Dermatomyositis, Graves Disease, Hashimoto Thyroiditis, Multiple Sclerosis, Myasthenia Gravis, Pernicious Anemia, Reactive Arthritis, Rheumatoid Arthritis, Sjogren syndrome, Systemic Lupus Erythematosus, and Type I Diabetes.
  • Based on Test, market is studied across Autoantibodies & Immunologic Test, Inflammatory Marker, and Routine Laboratory Test. The Autoantibodies & Immunologic Test is further studied across Anti-cyclic Citrullinated Peptide, Antinuclear Antibody, C-reactive Protein, Erythrocyte Sedimentation Rate, Rheumatoid Factor, and Thyroid Antibody Tests. The Thyroid Antibody Tests is further studied across T3, T3RU, T4, and TSH.
  • Based on Product, market is studied across Consumable & Assay Kit and Diagnostic Instrument.
  • Based on End User, market is studied across Clinical Laboratory and Hospital.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing Incidence of Autoimmune Diseases such as Rheumatoid Arthritis, Graves' disease and Hashimoto's thyroiditis
      • 5.1.1.2. Awareness Among Public About Autoimmune Diseases and Favorable Government Initiatives
      • 5.1.1.3. Improved Laboratory Techniques and Automation
    • 5.1.2. Restraints
      • 5.1.2.1. High Frequency of False Positive Results
      • 5.1.2.2. Slow Turnaround Time for Diagnostic Test
    • 5.1.3. Opportunities
      • 5.1.3.1. Adoption of Biosensors for Autoimmune Disease Diagnosis
      • 5.1.3.2. Strategic Partnerships Between Physicians and Clinical Laboratories
      • 5.1.3.3. Potential Growth in Reagent Rental Agreements and Collaboration Activities
    • 5.1.4. Challenges
      • 5.1.4.1. Cost associated with the diagnosis process
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Autoimmune Disease Diagnostics Market, by Type

  • 6.1. Introduction
  • 6.2. Localized Autoimmune Disease Diagnostics
  • 6.3. Systemic Autoimmune Disease Diagnostics

7. Autoimmune Disease Diagnostics Market, by Indication

  • 7.1. Introduction
  • 7.2. Addison Disease
  • 7.3. Celiac Disease
  • 7.4. Dermatomyositis
  • 7.5. Graves Disease
  • 7.6. Hashimoto Thyroiditis
  • 7.7. Multiple Sclerosis
  • 7.8. Myasthenia Gravis
  • 7.9. Pernicious Anemia
  • 7.10. Reactive Arthritis
  • 7.11. Rheumatoid Arthritis
  • 7.12. Sjogren syndrome
  • 7.13. Systemic Lupus Erythematosus
  • 7.14. Type I Diabetes

8. Autoimmune Disease Diagnostics Market, by Test

  • 8.1. Introduction
  • 8.2. Autoantibodies & Immunologic Test
    • 8.2.1. Anti-cyclic Citrullinated Peptide
    • 8.2.2. Antinuclear Antibody
    • 8.2.3. C-reactive Protein
    • 8.2.4. Erythrocyte Sedimentation Rate
    • 8.2.5. Rheumatoid Factor
    • 8.2.6. Thyroid Antibody Tests
      • 8.2.6.1. T3
      • 8.2.6.2. T3RU
      • 8.2.6.3. T4
      • 8.2.6.4. TSH
  • 8.3. Inflammatory Marker
  • 8.4. Routine Laboratory Test

9. Autoimmune Disease Diagnostics Market, by Product

  • 9.1. Introduction
  • 9.2. Consumable & Assay Kit
  • 9.3. Diagnostic Instrument

10. Autoimmune Disease Diagnostics Market, by End User

  • 10.1. Introduction
  • 10.2. Clinical Laboratory
  • 10.3. Hospital

11. Americas Autoimmune Disease Diagnostics Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Autoimmune Disease Diagnostics Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Autoimmune Disease Diagnostics Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2023
  • 14.2. FPNV Positioning Matrix, 2023
  • 14.3. Competitive Scenario Analysis
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. AESKU.GROUP GmbH & Co. KG
  • 3. AstraZeneca PLC
  • 4. Beckman Coulter, Inc.
  • 5. Bio-Rad Laboratories, Inc.
  • 6. BioAgilytix Labs
  • 7. Biogenuix Medsystems Private Limited
  • 8. bioMerieux SA
  • 9. EUROIMMUN Medical Laboratory Diagnostics AG
  • 10. Exagen Inc.
  • 11. F. Hoffmann-La Roche AG
  • 12. Hemagen Diagnostics, Inc.
  • 13. Novartis AG
  • 14. Pfizer Inc.
  • 15. Quest Diagnostics
  • 16. Sanofi S.A.
  • 17. SD BioSensor Inc.
  • 18. Siemens Healthineers AG
  • 19. SQI Diagnostics
  • 20. Thermo Fisher Scientific Inc.
  • 21. Trinity Biotech PLC
  • 22. Werfen Group

LIST OF FIGURES

  • FIGURE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 19. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 23. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 24. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 25. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTOIMMUNE DISEASE DIAGNOSTICS MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY LOCALIZED AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ADDISON DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CELIAC DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DERMATOMYOSITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY GRAVES DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HASHIMOTO THYROIDITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY MYASTHENIA GRAVIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PERNICIOUS ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY REACTIVE ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SJOGREN SYNDROME, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY SYSTEMIC LUPUS ERYTHEMATOSUS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE I DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTI-CYCLIC CITRULLINATED PEPTIDE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ANTINUCLEAR ANTIBODY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY C-REACTIVE PROTEIN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ERYTHROCYTE SEDIMENTATION RATE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY RHEUMATOID FACTOR, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T3RU, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY T4, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TSH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY MARKER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY ROUTINE LABORATORY TEST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CONSUMABLE & ASSAY KIT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC INSTRUMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY CLINICAL LABORATORY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY HOSPITAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 48. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 49. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 50. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 57. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 58. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 59. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ARGENTINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 61. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 63. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 64. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 65. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 66. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. BRAZIL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 68. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 70. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 71. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 72. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 73. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. CANADA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 77. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 78. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 79. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 80. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. MEXICO AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 82. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 84. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 85. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 86. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 87. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 89. UNITED STATES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 90. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 92. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 93. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 94. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 95. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 97. ASIA-PACIFIC AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 98. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 100. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 101. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 102. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 103. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 104. AUSTRALIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 107. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 108. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 109. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 110. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. CHINA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 112. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 114. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 115. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 116. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 117. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. INDIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 119. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 121. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 122. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 123. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 124. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. INDONESIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 126. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 129. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 130. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 131. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. JAPAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 133. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 135. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 136. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 137. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 138. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. MALAYSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 140. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 142. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 143. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 144. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 145. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. PHILIPPINES AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 147. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 150. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 151. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 152. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 153. SINGAPORE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 154. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 156. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 157. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH KOREA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 163. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 164. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 165. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 166. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. TAIWAN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 168. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 170. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 171. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 172. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 173. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. THAILAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 175. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 177. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 178. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 179. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 180. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. VIETNAM AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 182. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 185. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 186. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 187. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 189. EUROPE, MIDDLE EAST & AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 190. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 192. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 193. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 194. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 195. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. DENMARK AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 197. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 200. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 201. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 202. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 203. EGYPT AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 204. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 206. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 207. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 208. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 209. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 210. FINLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 213. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 214. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 215. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 216. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. FRANCE AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 218. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 220. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 221. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 222. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 223. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. GERMANY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 225. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 227. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 228. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 229. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 230. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. ISRAEL AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 232. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 235. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 236. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 237. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 238. ITALY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 239. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 241. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 242. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 243. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 244. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 245. NETHERLANDS AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 246. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 247. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 248. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 249. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 250. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 251. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 252. NIGERIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 253. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 255. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 256. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 257. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 258. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 259. NORWAY AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 260. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 261. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 262. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 263. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 264. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 265. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 266. POLAND AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 267. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 268. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 269. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 270. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 271. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 272. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 273. QATAR AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 274. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 275. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 276. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 277. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 278. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 279. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 280. RUSSIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 281. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 282. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 283. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 284. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 285. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 286. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 287. SAUDI ARABIA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 288. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 290. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 291. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 292. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 293. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 294. SOUTH AFRICA AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 295. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 296. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 297. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 298. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 299. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 300. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 301. SPAIN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 302. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 303. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 304. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY TEST, 2018-2030 (USD MILLION)
  • TABLE 305. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY AUTOANTIBODIES & IMMUNOLOGIC TEST, 2018-2030 (USD MILLION)
  • TABLE 306. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY THYROID ANTIBODY TESTS, 2018-2030 (USD MILLION)
  • TABLE 307. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 308. SWEDEN AUTOIMMUNE DISEASE DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 309. SWI